[MO31] Mini-Oral Session 31　Clinical Trial Facilitation Program 1（Trial in Progress）

[MO31-6] Efficacy and Safety of Perioperative Durvalumab for Superior Sulcus Tumors of Non-small Cell Lung Cancer: JCOG1807C

^○Yoshitaka Zenke¹, Keiju Aokage², Tsuboi Masahiro², Horinouchi Hidehito³, Nakamura Naoki⁴, Ishikura Satoshi⁵, Nishikawa Hiroyoshi⁶, Kumagai Shogo⁶, Koyama Shohei⁶, Kanato Keisuke⁷, Kataoka Tomoko⁷, Wakabayashi Masashi⁷, Sekino Yuta⁷, Fukutani Miki⁸, Chen-Yoshikawa Toyofumi⁹, Okada Morihito¹⁰, Takahama Makoto¹¹, Suzuki Kenji¹², Ohe Yuichiro³, Watabnabe Shun-Ichi¹³ (1.Department of Thoracic Oncology, National Cancer Center Hospital East, 2.Division of Thoracic Surgery, National Cancer Center Hospital East, 3.Division of Thoracic Oncology, National Cancer Center Hospital, 4.Department of Radiology, St. Marianna University School of Medicine, 5.Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 6.Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, 7.JCOG Data Center/Operations Office, National Cancer Center Hospital, 8.Clinical Research Support Office, National Cancer Center Hospital East, 9.Department of Thoracic Surgery, Nagoya University School of Medicine, 10.Department of Surgical Oncology, Hiroshima University, 11.Department of General Thoracic Surgery, Osaka City General Hospital, 12.Department of General Thoracic Surgery, Juntendo University School of Medicine, 13.Division of Thoracic Surgery, National Cancer Center Hospital)